Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.35 |
| ▸ | TUBB | P07437 | 1/20 | 0.35 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.35 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.35 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.35 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.35 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.35 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.35 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.35 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.35 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.35 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.35 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Alcohol SCHEMBL28721616 | 0.95 | CYP1A2 (0.42) | CYP2A6CYP1A2ALDH1A1KDM4EHTR2A | |
| SCHEMBL10997001 | 0.90 | CYP2A6 (0.38) | CYP2A6CYP1A2ALDH1A1KDM4EHTR2A | |
| SCHEMBL8955219 | 0.86 | CA12 (0.35) | CYP1A2ALDH1A1KDM4ESLC6A4MAPK1 | |
| SCHEMBL1372415 | 0.84 | ACHE (0.42) | CYP1A2ALDH1A1KDM4EHTR2AHPGD | |
| SCHEMBL1567602 | 0.84 | HPGD (0.36) | CYP2A6CYP1A2ALDH1A1KDM4EHTR2A | |
| SCHEMBL17789886 | 0.81 | SLC6A2 (0.39) | CYP1A2ALDH1A1KDM4EHTR2AHPGD | |
| SCHEMBL15350067 | 0.78 | TSHR (0.34) | ALDH1A1ALOX5MAPK1NPSR1 | |
| SCHEMBL21162070 | 0.78 | TSHR (0.34) | ALDH1A1ALOX5MAPK1NPSR1 | |
| SCHEMBL16177721 | 0.77 | CYP2A6 (0.40) | CYP2A6CYP1A2ALDH1A1KDM4EHTR2A | |
| SCHEMBL6202338 | 0.77 | CYP1A2 (0.43) | CYP2A6CYP1A2ALDH1A1KDM4EHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 281 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114213528-A | High-activity collagen filler and preparation method and application thereof | 兴业皮革科技股份有限公司 | 2022-03-22 | — | — | CN | claimed |
| CN-113912638-A | Polyaldehydic organic monomers based on siloxy compounds and process for their preparation | 吉林大学 | 2022-01-11 | — | — | CN | claimed |
| CN-110627852-B | Biotin-labeled naringin, preparation method and application thereof | 华中农业大学 | 2021-11-23 | — | — | CN | claimed |
| CN-110627852-A | Biotin-labeled naringin, preparation method and application thereof | 华中农业大学 | 2019-12-31 | — | — | CN | claimed |
| US-20260132295-A1 | COMPOUND, COMPOSITION, SURFACE TREATMENT AGENT, METHOD FOR MANUFACTURING ARTICLE, AND ARTICLE | AGC Inc. (JP) | 2026-05-14 | — | — | US | disclosed |
| US-12521395-B2 | Gem-disubstituted heterocyclic compounds and their use as IDH inhibitors | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2026-01-13 | — | — | US | disclosed |
| CN-120092003-A | CDK protein degrading agents, pharmaceutical compositions and therapeutic uses | 拜欧斯瑞克斯公司 | 2025-06-03 | — | — | CN | disclosed |
| EP-4055015-B1 | GEM-DISUBSTITUTED HETEROCYCLIC COMPOUNDS AND THEIR USE AS IDH INHIBITORS | NERVIANO MEDICAL SCIENCES SRL (IT) | 2025-04-02 | — | — | EP | disclosed |
| CN-115521328-B | Organic boron fluorescent material and preparation method and application thereof | 河南农业大学 | 2025-03-21 | — | — | CN | disclosed |
| WO-2025013913-A1 | COMPOUND, COMPOSITION, SURFACE TREATMENT AGENT, METHOD FOR PRODUCING ARTICLE, AND ARTICLE | ＡＧＣ株式会社 | 2025-01-16 | — | — | WO | disclosed |
| EP-3615515-B1 | PROPIONIC ACID DERIVATIVES AND METHODS OF USE THEREOF | AVIARA PHARMACEUTICALS INC (US) | 2024-09-25 | — | — | EP | disclosed |
| US-20240117152-A1 | NOVEL ORGANOSILICON COMPOUND, NOVEL CROSSLINKING AGENT, CURABLE COMPOSITION, PREPREG, MULTILAYER BODY, METAL CLAD LAMINATE AND WIRING BOARD | AGC Inc. (JP) | 2024-04-11 | — | — | US | disclosed |
| EP-0163416-B1 | PHENOL DERIVATIVES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-05-31 | — | — | EP | disclosed |
| US-4751240-A | ANTIFERTILITY AGENTS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-06-14 | — | — | US | disclosed |
| US-4699698-A | Preparation of benzoic acid ortho-esters and novel compounds of this type | BASF AKTIENGESELLSCHAFT (DE) | 1987-10-13 | — | — | US | disclosed |
| EP-0179289-B1 | METHOD FOR PRODUCING AROMATIC CARBOXYLIC ESTERS | BASF Aktiengesellschaft (DE) | 1987-07-08 | — | — | EP | disclosed |
| EP-0212509-A1 | Process for manufacturing benzoic-acid orthoesters, and compounds of this class | BASF Aktiengesellschaft (DE) | 1987-03-04 | — | — | EP | disclosed |
| US-4612092-A | TRIARYLAMINE, ELECTROLYSIS | BASF AKTIENGESELLSCHAFT (DE) | 1986-09-16 | — | — | US | disclosed |
| EP-0179289-A1 | Method for producing aromatic carboxylic esters | BASF Aktiengesellschaft (DE) | 1986-04-30 | — | — | EP | disclosed |
| EP-0163416-A2 | Phenol derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-12-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132295-A1 | COMPOUND, COMPOSITION, SURFACE TREATMENT AGENT, METHOD FOR MANUFACTURING ARTICLE, AND ARTICLE | MSR1, SEM1, ASH2L | CYP2A6 3611/4885CYP1A2 2477/4885ALDH1A1 2834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.